复发的儿童T细胞急性淋巴细胞白血病和淋巴细胞淋巴瘤
Andrew D Hughes1, Petri Pölönen2, David T Teachey3
1Division of Oncology, the Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. hughesa6@chop.edu.
Haematologica
|January 9, 2025
概括
再发性T细胞急性淋巴细胞白血病 (T-ALL) 和淋巴细胞淋巴瘤 (T-LBL) 的治疗具有挑战性. 新的精密药物和免疫疗法有望改善耐火性T-ALL/T-LBL的治疗结果.
科学领域:
- 儿科瘤学 儿科瘤学
- 血液学 血液学 血液学
- 免疫治疗是一种免疫疗法.
背景情况:
- 儿科急性淋巴细胞白血病 (ALL) 和淋巴细胞淋巴瘤 (LBL) 的结果有所改善,但复发性/耐药性疾病,特别是T细胞ALL/LBL,仍然是一个重大的挑战,生存率令人丧.
- 基因组分析提高了对T-ALL/LBL生物学的理解,有助于识别高风险患者和新的治疗点.
研究的目的:
- 审查目前对T-ALL/LBL复发风险因素的理解.
- 总结了复发性/耐药性T-ALL/LBL的既定治疗方案.
- 要突出有前途的新型小分子抑制剂和免疫疗法.
主要方法:
- 对T-ALL/LBL基因组学和治疗策略的最新文献的综述.
- 对目前研究新疗法的临床试验进行分析.
- 综合有关风险因素,当前治疗方法和新兴治疗方法的数据.
主要成果:
- 基因组洞察力改善了风险分层,并确定了T-ALL/LBL精准医学的目标.
- 新型免疫疗法在B细胞ALL中取得成功,在T-ALL/LBL临床试验中显示出有前途的早期结果.
- 小分子抑制剂和免疫疗法代表了复发/耐药T-ALL/LBL的潜在革命.
结论:
- 尽管面临挑战,但了解T-ALL/LBL生物学和开发有针对性和基于免疫的治疗方法的进展为改善患者的治疗结果提供了希望.
- 进一步的研究和临床试验至关重要,以充分实现新型疗法对于复发性/耐药性T-ALL/LBL的潜力.
更多相关视频
06:51Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
14.9K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.3K
相关概念视频
01:23Cells of the Adaptive Immune Response
951
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
951
01:20The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K